Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept

Poor responses to mRNA COVID-19 vaccine have been reported after 2 vaccine injections in kidney transplant recipients (KTRs) treated with belatacept. We analyzed the humoral response in belatacept-treated KTRs without a history of SARS-CoV-2 infection who received three injections of BNT162b2-mRNA C...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavarot, Nathalie, Morel, Antoine, Leruez-Ville, Marianne, Vilain, Estelle, Divard, Gillian, Burger, Carole, Serris, Alexandra, Sberro-Soussan, Rebecca, Martinez, Frank, Amrouche, Lucile, Bererhi, Lynda, Lanternier, Fanny, Legendre, Christophe, Zuber, Julien, Anglicheau, Dany, Scemla, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906354/
https://www.ncbi.nlm.nih.gov/pubmed/34431207
http://dx.doi.org/10.1111/ajt.16814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906354/
https://www.ncbi.nlm.nih.gov/pubmed/34431207
http://dx.doi.org/10.1111/ajt.16814

Ejemplares similares